• In May 2026, CareTrust REIT, Inc. reported first-quarter 2026 results showing revenue rising to US$142.78 million and net income reaching US$80.21 million, and it raised its 2026 guidance to project net income attributable to CareTrust of US$348 million to US$358 million, or US$1.49 to US$1.53 per share.
• The combination of higher quarterly revenue, increased net income, and an upward revision to full-year earnings guidance signals improving operating trends across CareTrust’s senior housing and healthcare property portfolio.
• We’ll now examine how CareTrust’s upgraded 2026 earnings guidance reshapes its existing investment narrative built around growth, diversification, and risk.

Find 51 companies with promising cash flow potential yet trading below their fair value.

CareTrust REIT Investment Narrative Recap

To own CareTrust REIT, you need to believe in a growing, diversified portfolio of senior housing and healthcare properties that can support steady earnings and dividends over time. The raised 2026 net income guidance, following stronger first quarter results, reinforces that story in the near term, although rapid capital deployment into new assets and markets still leaves integration and execution as the key short term catalyst and the most immediate risk.

Among recent announcements, the March 2026 dividend increase to US$0.39 per share stands out in light of the higher full year earnings guidance. While the payout is not fully covered by earnings, the combination of higher projected net income and ongoing acquisitions in the U.S. and U.K. suggests management is leaning on portfolio growth and rental income visibility as support for the higher distribution, which ties directly into the core earnings catalyst investors are watching.

Yet, investors should also weigh how expanding into U.K. care homes could expose CareTrust to unfamiliar regulatory and reimbursement risks that...

CareTrust REIT's narrative projects $848.5 million revenue and $473.7 million earnings by 2029. This requires 17.5% yearly revenue growth and a $138.7 million earnings increase from $335.0 million today.

Uncover how CareTrust REIT's forecasts yield a $43.67 fair value, a 6% upside to its current price.

Exploring Other Perspectives

Seven members of the Simply Wall St Community have published fair value estimates for CareTrust, ranging from US$26.24 to US$83.38 per share. Against this wide spread of views, the recent earnings beat and higher 2026 guidance highlight how rapidly expanding the portfolio can both support growth expectations and amplify concerns about integration risk, giving you several distinct angles to consider.

Explore 7 other fair value estimates on CareTrust REIT - why the stock might be worth over 2x more than the current price!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your CareTrust REIT research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free CareTrust REIT research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate CareTrust REIT's overall financial health at a glance.

Ready For A Different Approach?

Our top stock finds are flying under the radar-for now. Get in early:

• This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 17 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• The future of work is here. Discover the 34 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.